The World Health Organisation declared a Public Health Event of International Concern on Friday after a novel respiratory variant, provisionally designated RV-26, spread to 18 countries in six weeks. The declaration — the highest level of alert the WHO can issue — triggers an international coordinated response and obliges member states to report cases through official channels.
The variant was first identified in late May in three patients admitted to a hospital in northern Italy. Genomic sequencing confirmed it was distinct from any previously catalogued respiratory pathogen, though early analysis suggests it shares structural features with a family of coronaviruses. The WHO's director-general, speaking at a press conference in Geneva, emphasised that the declaration did not mean a pandemic was inevitable. "We are acting early, precisely so that we do not have to act late," she said.
As of Thursday, confirmed cases stood at 847 across Europe, North America and parts of Asia. The case fatality rate remains difficult to calculate at this stage, but early hospital data from Italy and France suggests severe illness in approximately 4 per cent of confirmed cases, predominantly in older adults and those with pre-existing conditions. The UK Health Security Agency said it was "monitoring the situation closely" and had activated its incident response team.
Vaccine manufacturers including AstraZeneca and Moderna said they had begun preliminary work on candidate vaccines and could potentially produce initial doses within four to six months if the variant's genome proved amenable to existing mRNA platforms. The WHO's chief scientist cautioned against drawing premature conclusions from early data, noting that the picture could change significantly as testing capacity expanded in affected countries.